Biomarkers for Hunter Syndrome

Clinical trial NCT01330277 · TERMINATED

Trial details

NCT number: NCT01330277
Sponsor: CENTOGENE GmbH Rostock
Status: TERMINATED
Study type: OBSERVATIONAL

Hunter Syndrome Mucopolysaccharidosis II Hunter's Syndrome, Mild Form Hunter's Canal Syndrome

Start date: 2018-08-20
Primary completion: 2022-12-31
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.